0216/26SCR018-12/R4RGB
Media Highlights
From the 2025 ASH Annual Meeting
6
Media Outlet Article / Coverage
Cancer Nursing Today ASH Annual Meeting 2025: Krish Patel, MD, Highlights Quality
Improvement Initiative for Toxicity Management of Diffuse Large
B-Cell Lymphoma
Oncology Learning Network Analyzing Patient Preferences on Follicular Lymphoma Treatment
Delivery Options
Oncology Learning Network Quality Improvement Project Identifies Knowledge Gaps and
Barriers to Bispecific Antibody Use in Community Oncology
Practices
Targeted Oncology Latest Advances in Lymphoma and CLL Treatment: Insights from
Dr Krish Patel
VJHemOnc Quality Improvement Initiative to Optimize AE Management for
Bispecifics for DLBCL in the Community
VJHemOnc Phase I Trial of LY4152199, a BAFF-R-targeting Bispecific, in
Previously Treated B-cell Malignancies
VJHemOnc Outpatient Use of Liso-Cel in Patients With R/R LBCL: Real-world
Data From the CIBMTR Registry
VuMedi ASH 2025 Insights: Diverse Preferences for Treatment Options in
R/R FL - Survey Results From Patients in the US
VuMedi ASH 2025 Insights: Optimizing Processes for Adverse Event
Management for Bispecific Antibodies for DLBCL in Community
Practice
Krish Patel, MD
SCRI
